Global Bio-chem Updates Nomination Committee Terms to Strengthen Governance and Diversity

The latest update is out from Global Bio-chem Technology Group Co. Ltd. ( (HK:0809) ).

Global Bio-chem Technology Group Company Limited has updated the terms of reference for its Board Nomination Committee, effective from 1 April 2012 and amended on 30 August 2013 and 18 December 2025. The revised document sets out the committee’s constitution, membership structure and governance arrangements, requiring at least three directors as members, a majority of whom must be independent non-executive directors, with at least one member of a different gender, and designating either the Board chairman or an independent non-executive director as committee chair, while the company secretary serves as committee secretary. These changes reinforce the company’s corporate governance framework, strengthen independence and diversity in board nominations, and signal ongoing efforts to align with evolving regulatory and best-practice standards, which may enhance oversight and confidence among investors and other stakeholders.

The most recent analyst rating on (HK:0809) stock is a Hold with a HK$0.08 price target. To see the full list of analyst forecasts on Global Bio-chem Technology Group Co. Ltd. stock, see the HK:0809 Stock Forecast page.

More about Global Bio-chem Technology Group Co. Ltd.

Global Bio-chem Technology Group Company Limited is a Hong Kong-listed enterprise engaged in biochemical technology, operating in the bio-chem sector. The company focuses on corn-based biochemical products and related downstream applications, serving industrial and consumer markets that use bio-based materials and ingredients.

Average Trading Volume: 7,270,533

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$1.09B

Find detailed analytics on 0809 stock on TipRanks’ Stock Analysis page.